AML across two trials Introduces first trispecific molecules, APVO451 and APVO452, advancing therapies designed to overcome immune suppression in certain solid ...

Kinterra Capital Corp. ("Kinterra") and its operating subsidiary, Southwest Critical Materials LLC, are pleased to announce receipt of a Non-Binding Letter of Interest from the Export-Import Bank of ...